OncoSil Medical Secures TGA Approval in Australia for Pancreatic Cancer Device
· smallcaps.com.au
OncoSil Medical wins TGA approval for OncoSil device to treat unresectable LAPC; ARTG-listed, enabling Australian launch as manufacturing scales up.
OncoSil Medical (ASX: OSL) has received approval from the Australian Therapeutic Goods Administration (TGA) for its OncoSil Class III medical device.
The appro...